Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Verastem, Inc. | 100,118 | reported | 08 Jan 2015 | tx 4+400,868 |
| IDERA PHARMACEUTICALS, INC. | 45,500 | reported | 09 Jul 2019 | tx 9+1,196,900 |
| Liquidia Corp | 33,755 | reported | 19 Aug 2025 | tx 7+134,627−5,000 |
| CANCER GENETICS, INC | 23,123 | reported | 17 Jan 2023 | tx 8+103,603 |
| Liquidia Technologies Inc | 20,000 | reported | 22 Jun 2020 | tx 2+35,000 |
| Kymera Therapeutics, Inc. | 8,500 | reported | 07 Jun 2024 | tx 8+92,690−17,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Aug 2025 | SALE | Liquidia Corp | 5,000 | 27.17 USD | |
| 17 Jun 2025 | GRANT_AWARD | Liquidia Corp | 18,396 | 0.00 USD | |
| 20 Jun 2024 | GRANT_AWARD | Liquidia Corp | 20,359 | 0.00 USD | |
| 07 Jun 2024 | SALE | Kymera Therapeutics, Inc. | 2,187 | 32.65 USD | |
| 07 Jun 2024 | EXERCISE | Kymera Therapeutics, Inc. | 8,500 | 2.08 USD | |
| 07 Jun 2024 | SALE | Kymera Therapeutics, Inc. | 6,313 | 33.11 USD | |
| 07 Jun 2024 | EXERCISE | Kymera Therapeutics, Inc. | 8,500 | 0.00 USD | deriv |
| 19 Jun 2023 | GRANT_AWARD | Liquidia Corp | 20,000 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | Kymera Therapeutics, Inc. | 12,000 | 0.00 USD | deriv |
| 17 Jan 2023 | GRANT_AWARD | CANCER GENETICS, INC | 7,526 | — | |
| 17 Oct 2022 | GRANT_AWARD | CANCER GENETICS, INC | 14,285 | — | |
| 18 Jul 2022 | GRANT_AWARD | CANCER GENETICS, INC | 8,092 | — | |
| 17 Jun 2022 | GRANT_AWARD | Liquidia Corp | 20,000 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | Kymera Therapeutics, Inc. | 12,000 | 0.00 USD | deriv |
| 18 Apr 2022 | GRANT_AWARD | CANCER GENETICS, INC | 6,796 | — | |
| 30 Mar 2022 | GRANT_AWARD | CANCER GENETICS, INC | 43,478 | — | |
| 18 Jan 2022 | GRANT_AWARD | CANCER GENETICS, INC | 5,343 | 1.31 USD | |
| 20 Aug 2021 | GRANT_AWARD | Liquidia Corp | 20,000 | 0.00 USD | deriv |
| 16 Jun 2021 | GRANT_AWARD | Kymera Therapeutics, Inc. | 20,063 | 0.00 USD | deriv |
| 30 Mar 2021 | GRANT_AWARD | CANCER GENETICS, INC | 13,015 | 0.00 USD | deriv |
| 30 Mar 2021 | OTHER | CANCER GENETICS, INC | 5,068 | 0.00 USD | deriv |
| 24 Mar 2021 | GRANT_AWARD | Liquidia Corp | 35,872 | 0.00 USD | deriv |
| 20 Aug 2020 | GRANT_AWARD | Kymera Therapeutics, Inc. | 40,127 | 0.00 USD | deriv |
| 22 Jun 2020 | GRANT_AWARD | Liquidia Technologies Inc | 20,000 | 0.00 USD | deriv |
| 11 Sept 2019 | GRANT_AWARD | Liquidia Technologies Inc | 15,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 20 Dec 2018.